Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis.
N Engl J Med
; 379(1): 11-21, 2018 07 05.
Article
in En
| MEDLINE
| ID: mdl-29972753
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Amyloid Neuropathies, Familial
/
RNA, Small Interfering
/
RNAi Therapeutics
Type of study:
Clinical_trials
/
Etiology_studies
Limits:
Adult
/
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
N Engl J Med
Year:
2018
Type:
Article